Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00875

Related search